Ulocuplumab

DB12018InvestigationalProtein Based Therapies

Ulocuplumab is under investigation in Solid Tumor.

Mechanism: Pharmacologically active on C-X-C chemokine receptor type 4
Curator reviewed
Code names: Bms 936564

Resolves to

Compound

Targets

What you can answer from here — as of June 28, 2022

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ulocuplumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.